Abstract
The differential diagnosis of vertigo or dizziness as a result of cerebellar disorders can be difficult as many patients with a cerebellar pathology do not present with the full spectrum of cerebellar signs. The main goal of this study was to describe the typical clinical features of these patients with vertigo or dizziness of a cerebellar origin. We reviewed the medical records of 5400 patients with vertigo and dizziness from our tertiary outpatient clinic for vertigo and balance disorders. In 459 the diagnosis of “cerebellar vertigo or dizziness” was made; 90 patients were excluded from further analysis due to evident structural changes in MRI. Of the remaining 369 patients (67.0 ± 15.1, 54% female, symptom duration until diagnosis 5.5 ± 6.9 years), 81% suffered from persistent vertigo or dizziness, 31% from attacks of vertigo and dizziness and 21% from both. Neuro-ophthalmologically, 95% had saccadic smooth pursuit, 80% gaze-holding deficits, 64% a pathological fixation suppression of the VOR, 24% central fixation nystagmus (in 64% of these cases downbeat nystagmus (DBN)), 23% rebound nystagmus, and an ocular misalignment in 84% in near view and 50% in distance view. Eleven percent had isolated mild to moderate cerebellar ocular motor disturbances without any other typical cerebellar signs. The most common diagnoses were sporadic adult-onset degenerative ataxia in 26%; idiopathic DBN syndrome in 20%; cerebellar ataxia, neuropathy, and vestibular areflexia syndrome in 10%; episodic ataxia type 2 in 7%; and multiple system atrophy cerebellar type in 6%. In posturography, a typical cerebellar 3-Hz sway was found in 16%. The diagnostic key to patients with cerebellar vertigo or dizziness is a careful examination of eye movements since practically all of them have cerebellar ocular disturbances.
Similar content being viewed by others
References
Corrales CE, Bhattacharyya N. Dizziness and death: an imbalance in mortality. Laryngoscope. 2016;126(9):2134–6.
Brandt T, Dieterich M, Strupp M. Vertigo and dizziness - common complaints, Vol. 2. Springer; 2013.
Kim JS, Lee H. Vertigo due to posterior circulation stroke. Semin Neurol. 2013;33(3):179–84.
Lee H. Neuro-otological aspects of cerebellar stroke syndrome. J Clin Neurol. 2009;5(2):65–73.
Grimaldi G, Manto M. Topography of cerebellar deficits in humans. Cerebellum. 2012;11(2):336–51.
Bodranghien F, Bastian A, Casali C, Hallett M, Louis ED, Manto M, et al. Consensus paper: revisiting the symptoms and signs of cerebellar syndrome. Cerebellum. 2016;15(3):369–91.
Leigh RJ, Zee DS, editors. The Neurology of Eye Movements. 5th ed. Oxford, New York: Oxford University Press; 2015.
Diener HC, Dichgans J, Bacher M, Gompf B. Quantification of postural sway in normals and patients with cerebellar diseases. Electroencephalogr Clin Neurophysiol. 1984;57(2):134–42.
Baloh RW, Konrad HR, Honrubia V. Vestibulo-ocular function in patients with cerebellar atrophy. Neurology. 1975;25(2):160–8.
Thurston SE, Leigh RJ, Abel LA, Dell'Osso LF. Hyperactive vestibulo-ocular reflex in cerebellar degeneration: pathogenesis and treatment. Neurology. 1987;37(1):53–7.
Klockgether T. Sporadic adult-onset ataxia. Handb Clin Neurol. 2018;155:217–25.
Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670–6.
Szmulewicz DJ, Roberts L, McLean CA, MacDougall HG, Halmagyi GM, Storey E. Proposed diagnostic criteria for cerebellar ataxia with neuropathy and vestibular areflexia syndrome (CANVAS). Neurol Clin Pract. 2016;6(1):61–8.
Hufner K, et al. Esophoria or esotropia in adulthood: a sign of cerebellar dysfunction? J Neurol. 2015;262(3):585–92.
Schneider E, Villgrattner T, Vockeroth J, Bartl K, Kohlbecher S, Bardins S, et al. EyeSeeCam: an eye movement-driven head camera for the examination of natural visual exploration. Ann N Y Acad Sci. 2009;1164:461–7.
Bremova-Ertl T, et al. Oculomotor and vestibular findings in Gaucher disease type 3 and their correlation with neurological findings. Front Neurol. 2017;8:711.
Strupp M, Kim JS, Murofushi T, Straumann D, Jen JC, Rosengren SM, et al. Bilateral vestibulopathy: diagnostic criteria consensus document of the classification Committee of the Barany Society. J Vestib Res. 2017;27(4):177–89.
Krafczyk S, Tietze S, Swoboda W, Valkovič P, Brandt T. Artificial neural network: a new diagnostic posturographic tool for disorders of stance. Clin Neurophysiol. 2006;117(8):1692–8.
Subramony SH. SARA--a new clinical scale for the assessment and rating of ataxia. Nat Clin Pract Neurol. 2007;3(3):136–7.
R Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing; 2018. https://www.R-project.org/.
Claassen J, Feil K, Bardins S, Teufel J, Spiegel R, Kalla R, et al. Dalfampridine in patients with downbeat nystagmus--an observational study. J Neurol. 2013;260(8):1992–6.
Claassen J, Spiegel R, Kalla R, Faldon M, Kennard C, Danchaivijitr C, et al. A randomised double-blind, cross-over trial of 4-aminopyridine for downbeat nystagmus--effects on slowphase eye velocity, postural stability, locomotion and symptoms. J Neurol Neurosurg Psychiatry. 2013;84(12):1392–9.
Claassen J, Teufel J, Kalla R, Spiegel R, Strupp M. Effects of dalfampridine on attacks in patients with episodic ataxia type 2: an observational study. J Neurol. 2013;260(2):668–9.
Strupp M, Kalla R, Claassen J, Adrion C, Mansmann U, Klopstock T, et al. A randomized trial of 4-aminopyridine in EA2 and related familial episodic ataxias. Neurology. 2011;77(3):269–75.
Strupp M, Kalla R, Dichgans M, Freilinger T, Glasauer S, Brandt T. Treatment of episodic ataxia type 2 with the potassium channel blocker 4-aminopyridine. Neurology. 2004;62(9):1623–5.
Strupp M, Schuler O, Krafczyk S, Jahn K, Schautzer F, Buttner U, et al. Treatment of downbeat nystagmus with 3,4-diaminopyridine: a placebo-controlled study. Neurology. 2003;61(2):165–70.
Strupp M, Teufel J, Habs M, Feuerecker R, Muth C, van de Warrenburg BP, et al. Effects of acetyl-DL-leucine in patients with cerebellar ataxia: a case series. J Neurol. 2013;260(10):2556–61.
Li X, Wang Y, Wang Z, Xu Y, Zheng W. 3-Hz postural tremor in multiple system atrophy cerebellar type (MSA-C)-a static posturography study. Neurol Sci. 2018;39(1):71–7.
Kremmyda O, et al. False-positive head-impulse test in cerebellar ataxia. Front Neurol. 2012;3:162.
Kirchner H, Kremmyda O, Hüfner K, Stephan T, Zingler V, Brandt T, et al. Clinical, electrophysiological, and MRI findings in patients with cerebellar ataxia and a bilaterally pathological head-impulse test. Ann N Y Acad Sci. 2011;1233:127–38.
Bronstein AM, Hood JD. Cervical nystagmus due to loss of cerebellar inhibition on the cervico-ocular reflex: a case report. J Neurol Neurosurg Psychiatry. 1985;48(2):128–31.
Yu-Wai-Man P, Gorman G, Bateman DE, Leigh RJ, Chinnery PF. Vertigo and vestibular abnormalities in spinocerebellar ataxia type 6. J Neurol. 2009;256(1):78–82.
Acknowledgments
We thank Katie Göttlinger for copy-editing the manuscript. We thank the team of the neuro-orthoptists for the neuro-ophthalmological examination of the patients.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
The study was approved by the ethics committee of the Ludwig-Maximilians University Munich and was performed in accordance with the ethical standards according to the 1964 Declaration of Helsinki and its later amendments.
Competing Interests
K. Feil reports no disclosures.
R. Strobl reports no disclosures.
A. Schindler reports no disclosures.
S: Krafczyk reports no disclosures.
N. Goldschagg received honoraria for lecturing from Actelion.
C. Frenzel reports no disclosures.
M. Glaser reports no disclosures.
F. Schöberl reports no disclosures.
A. Zwergal reports no disclosures.
M. Strupp is Joint Chief Editor of the Journal of Neurology, Editor in Chief of Frontiers of Neuro-otology, and Section Editor of F1000. He has received speaker’s honoraria from Abbott, Actelion, Auris Medical, Biogen, Eisai, Grünenthal, GSK, Henning Pharma, Interacoustics, MSD, Otometrics, Pierre-Fabre, TEVA, and UCB. He is a shareholder in IntraBio. He acts as a consultant for Abbott, Actelion, AurisMedical, Heel, IntraBio, and Sensorion.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Feil, K., Strobl, R., Schindler, A. et al. What Is Behind Cerebellar Vertigo and Dizziness?. Cerebellum 18, 320–332 (2019). https://doi.org/10.1007/s12311-018-0992-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12311-018-0992-8